{"id":273745,"date":"2026-09-28T10:44:10","date_gmt":"2026-09-28T05:14:10","guid":{"rendered":"https:\/\/univest.in\/blogs-2\/?p=273745"},"modified":"2026-09-28T10:44:10","modified_gmt":"2026-09-28T05:14:10","slug":"why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28","status":"publish","type":"post","link":"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/","title":{"rendered":"Glenmark Pharmaceuticals (GLENMARK) Share Price Falls 2% Today"},"content":{"rendered":"<div class=\"univest-blue-summary\" style=\"border-left:4px solid #1F4E79;background:#EBF3FB;padding:12px 16px;margin:0 0 18px 0;font-style:italic;\"><em><a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals (GLENMARK)<\/a> share price fell to Rs 2,335.35 today, down 2% from the previous close. Market cap was Rs 67,254.14 crore.<\/em><\/div>\n<p class=\"univest-article-timestamp\" style=\"font-size:14px;color:#5F6673;margin:8px 0 18px 0;;margin-top:0!important;margin-bottom:0!important;\"><strong>Published:<\/strong>&nbsp;&nbsp;&nbsp;28 September 2026 at 10:23:33 AM IST<\/p>\n<p style=\"margin-top:0!important;\">Glenmark Pharmaceuticals Share Price was lower in today\u2019s session, with Glenmark Pharmaceuticals trading at Rs 2,335.35, down 2% from the previous close of Rs 2,383. The company\u2019s market capitalisation stood at Rs 67,254.14 crore, placing it in the Large Cap category. The move is relevant because Glenmark Pharmaceuticals Share Price today is being watched alongside the broader Glenmark Pharmaceuticals stock news flow, even though the supplied data does not establish a company-specific catalyst for the decline. For readers tracking Glenmark Pharmaceuticals share price news, the key facts are the current price, the day\u2019s percentage fall, and the company\u2019s valuation and sector context. Univest is presenting the event strictly from the verified numbers supplied in the workflow.<\/p>\n<p>Within today\u2019s session, Glenmark Pharmaceuticals Share Price moved between Rs 2,398.80 and Rs 2,330. The stock opened at Rs 2,398.80, matched that level as the day\u2019s high, and touched the low of Rs 2,330 before closing at Rs 2,335.35. The session therefore left Glenmark Pharmaceuticals Share Price update readers with a lower close than both the open and the previous close. Univest notes the exact turnover of Rs 1.26 crore as a factual market-value figure. Since the supplied data confirms the price event but does not establish a company-specific catalyst, the focus stays on price action, fundamentals, sector positioning and peer comparison.<\/p>\n<div id=\"ez-toc-container\" class=\"ez-toc-v2_0_65 counter-hierarchy ez-toc-counter ez-toc-grey ez-toc-container-direction\">\n<div class=\"ez-toc-title-container\">\n<p class=\"ez-toc-title \" >Table of Contents<\/p>\n<span class=\"ez-toc-title-toggle\"><a href=\"#\" class=\"ez-toc-pull-right ez-toc-btn ez-toc-btn-xs ez-toc-btn-default ez-toc-toggle\" aria-label=\"Toggle Table of Content\"><span class=\"ez-toc-js-icon-con\"><span class=\"\"><span class=\"eztoc-hide\" style=\"display:none;\">Toggle<\/span><span class=\"ez-toc-icon-toggle-span\"><svg style=\"fill: #999;color:#999\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" class=\"list-377408\" width=\"20px\" height=\"20px\" viewBox=\"0 0 24 24\" fill=\"none\"><path d=\"M6 6H4v2h2V6zm14 0H8v2h12V6zM4 11h2v2H4v-2zm16 0H8v2h12v-2zM4 16h2v2H4v-2zm16 0H8v2h12v-2z\" fill=\"currentColor\"><\/path><\/svg><svg style=\"fill: #999;color:#999\" class=\"arrow-unsorted-368013\" xmlns=\"http:\/\/www.w3.org\/2000\/svg\" width=\"10px\" height=\"10px\" viewBox=\"0 0 24 24\" version=\"1.2\" baseProfile=\"tiny\"><path d=\"M18.2 9.3l-6.2-6.3-6.2 6.3c-.2.2-.3.4-.3.7s.1.5.3.7c.2.2.4.3.7.3h11c.3 0 .5-.1.7-.3.2-.2.3-.5.3-.7s-.1-.5-.3-.7zM5.8 14.7l6.2 6.3 6.2-6.3c.2-.2.3-.5.3-.7s-.1-.5-.3-.7c-.2-.2-.4-.3-.7-.3h-11c-.3 0-.5.1-.7.3-.2.2-.3.5-.3.7s.1.5.3.7z\"\/><\/svg><\/span><\/span><\/span><\/a><\/span><\/div>\n<nav><ul class='ez-toc-list ez-toc-list-level-1 ' ><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-1\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Glenmark_Pharmaceuticals_GLENMARK_Share_Price_Today_Price_Action_Analysis\" title=\"Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis\">Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-2\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Glenmark_Pharmaceuticals_GLENMARK_Fundamental_Analysis\" title=\"Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis\">Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-3\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Sector_and_Industry_Context\" title=\"Sector and Industry Context\">Sector and Industry Context<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-4\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Peer_Comparison\" title=\"Peer Comparison\">Peer Comparison<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-5\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\" title=\"Why Investors Are Watching Glenmark Pharmaceuticals\">Why Investors Are Watching Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-6\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#About_Glenmark_Pharmaceuticals\" title=\"About Glenmark Pharmaceuticals\">About Glenmark Pharmaceuticals<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-7\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\" title=\"Track Glenmark Pharmaceuticals Share Price on Univest\">Track Glenmark Pharmaceuticals Share Price on Univest<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-2'><a class=\"ez-toc-link ez-toc-heading-8\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Frequently_Asked_Questions\" title=\"Frequently Asked Questions\">Frequently Asked Questions<\/a><ul class='ez-toc-list-level-3' ><li class='ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-9\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#Why_did_Glenmark_Pharmaceuticals_Share_Price_fall_today\" title=\"Why did Glenmark Pharmaceuticals Share Price fall today?\">Why did Glenmark Pharmaceuticals Share Price fall today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-10\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#What_was_Glenmark_Pharmaceuticals_Share_Price_today\" title=\"What was Glenmark Pharmaceuticals Share Price today?\">What was Glenmark Pharmaceuticals Share Price today?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-11\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#What_is_Glenmark_Pharmaceuticals_market_capitalisation\" title=\"What is Glenmark Pharmaceuticals market capitalisation?\">What is Glenmark Pharmaceuticals market capitalisation?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-12\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#How_does_Glenmark_Pharmaceuticals_compare_with_sector_peers\" title=\"How does Glenmark Pharmaceuticals compare with sector peers?\">How does Glenmark Pharmaceuticals compare with sector peers?<\/a><\/li><li class='ez-toc-page-1 ez-toc-heading-level-3'><a class=\"ez-toc-link ez-toc-heading-13\" href=\"https:\/\/univest.in\/blogs-2\/why-glenmark-pharmaceuticals-share-price-price-fall-2026-09-28\/#What_do_Glenmark_Pharmaceuticals_fundamentals_show\" title=\"What do Glenmark Pharmaceuticals fundamentals show?\">What do Glenmark Pharmaceuticals fundamentals show?<\/a><\/li><\/ul><\/li><\/ul><\/nav><\/div>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_GLENMARK_Share_Price_Today_Price_Action_Analysis\"><\/span><strong>Glenmark Pharmaceuticals (GLENMARK) Share Price Today: Price Action Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Current Price<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,335.35<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Previous Close<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,383<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Today&#39;s Move<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">-Rs 47.65 (-2%)<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Open<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,398.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>High<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,398.8<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Low<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 2,330<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Turnover<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 1.26 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67,254.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Cap Category<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Large Cap<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals Share Price today reflected a decline of Rs 47.65, or 2%, from the previous close of Rs 2,383 to Rs 2,335.35. The day opened at Rs 2,398.80, which was also the high, and then moved to a low of Rs 2,330 before settling near that lower end. That sequence shows a session that ended below the open, below the previous close and close to the intraday low. For a reader following Glenmark Pharmaceuticals share price fall, the important point is the exact path of the move, not an assumed reason.<\/p>\n<p>The stock\u2019s market capitalisation of Rs 67,254.14 crore places it in the Large Cap category, and the exact turnover reported for the day was Rs 1.26 crore. Those facts define the day\u2019s trading snapshot without adding any unverified interpretation. In Glenmark Pharmaceuticals stock analysis terms, the verified data confirms a negative day for price, but it does not by itself explain the trigger. That makes the stock part of Glenmark Pharmaceuticals stock news and Glenmark Pharmaceuticals News Today only on the basis of the observed session data. From here, the discussion shifts to fundamentals, valuation and sector context, which can help frame Glenmark Pharmaceuticals Share Price in a broader research setting.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Glenmark_Pharmaceuticals_GLENMARK_Fundamental_Analysis\"><\/span><strong>Glenmark Pharmaceuticals (GLENMARK) Fundamental Analysis<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67,254.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">37.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.14x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>EPS<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 63.7<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Book Value Per Share<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 388.43<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Dividend Yield<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">0.1%<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>EPS is Rs 63.70, which tells readers how much earnings are attributable to each share. Book value is Rs 388.43 per share, which shows the accounting net worth behind each share, while dividend yield is 0.10%, a small historical payout metric relative to the current price. In Glenmark Pharmaceuticals Share Price terms, these figures indicate that today\u2019s decline should be viewed alongside a business that still carries a premium valuation compared with the wider industry set. The supplied financial metrics support Glenmark Pharmaceuticals Stock Analysis by giving a clear valuation and profitability backdrop, rather than a directional call. Univest highlights these numbers because they matter to anyone comparing Glenmark Pharmaceuticals Share Price Today with the company\u2019s longer-term operating profile.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Sector_and_Industry_Context\"><\/span><strong>Sector and Industry Context<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Metric<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:10px 12px;background:#F7F9FC;\">Value<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Sector<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Healthcare<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Industry<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Pharmaceuticals &amp; Drugs<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Scope<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">same industry<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/E Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">37.41x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">32.87x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/E<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">49.63x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark P\/E Range<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">3.46x to 735.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company P\/B Ratio<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">6.14x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">2.85x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average P\/B<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">4.33x<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">14.1%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">11.48%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">10.04%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">20.35%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">13.17%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average ROCE<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">12.82%<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Company Market Capitalisation<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 67,254.14 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Median Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 732.57 crore<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\"><strong>Benchmark Average Market Cap<\/strong><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:10px 12px;\">Rs 14,043.26 crore<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals operates in Healthcare, within the Pharmaceuticals &amp; Drugs industry. The sector benchmark supplied here covers the same industry and includes 204 companies, which gives a broad comparison base for Glenmark Pharmaceuticals Share Price and Glenmark Pharmaceuticals Share Price Today. Glenmark\u2019s P\/E of 37.41 is above the industry median of 32.87 and below the industry average of 49.63, while its P\/B of 6.14 is above the median of 2.85 and above the average of 4.33. Those numbers show how the company sits versus a wide industry sample, without needing any outside assumptions.<\/p>\n<p>On profitability, Glenmark\u2019s ROE of 14.10% is above the industry median of 11.48% and above the average of 10.04%, while ROCE of 20.35% is above the industry median of 13.17% and above the average of 12.82%. The sector benchmark also shows a market-cap median of Rs 732.57 crore and an average of Rs 14,043.26 crore, while Glenmark\u2019s market capitalisation is Rs 67,254.14 crore. That places Glenmark well above the median and average company size in this sample. For readers following Glenmark Pharmaceuticals stock news, the sector context explains why Glenmark Pharmaceuticals Share Price remains important in the healthcare universe: the company\u2019s valuation and return metrics are not isolated numbers, but part of a wider industry comparison.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Peer_Comparison\"><\/span><strong>Peer Comparison<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<table style=\"width:100%;border-collapse:collapse;margin:16px 0 22px 0;\">\n<thead>\n<tr>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Company<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Symbol<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">Market Cap (Cr)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/E<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">P\/B<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROE (%)<\/th>\n<th style=\"text-align:left;border:1px solid #E3E7EE;padding:8px;background:#F7F9FC;\">ROCE (%)<\/th>\n<\/tr>\n<\/thead>\n<tbody>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/sunpharma\/sun-pharmaceutical-industries-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Sun Pharmaceutical Industries<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">SUNPHARMA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4,44,716.74<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">36.77<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">5.14<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.85<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.11<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/divislab\/divi-s-laboratories-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Divi&#39;s Laboratories<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">DIVISLAB<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">2,55,115.31<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">87.22<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">14.44<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16.19<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.51<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/torntpharm\/torrent-pharmaceuticals-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Torrent Pharmaceuticals<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">TORNTPHARM<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,89,613.38<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">86.94<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.13<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.76<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.27<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/zyduslife\/zydus-lifesciences-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Zydus Lifesciences<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">ZYDUSLIFE<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,19,899.96<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">26.57<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">4.45<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">19.69<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">21.39<\/td>\n<\/tr>\n<tr>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\"><a href=\"https:\/\/univest.in\/stocks\/cipla\/cipla-ltd-share-price-today\" style=\"color:#0645AD;text-decoration:underline;\"><strong>Cipla<\/strong><\/a><\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">CIPLA<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">1,12,875.68<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">33.49<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">3.21<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">11.83<\/td>\n<td style=\"border:1px solid #E3E7EE;padding:8px;\">16<\/td>\n<\/tr>\n<\/tbody>\n<\/table>\n<p>Glenmark Pharmaceuticals Share Price can also be viewed against listed peers in the same industry. Glenmark\u2019s P\/E of 37.41 is higher than Zydus Lifesciences at 26.57, Dr. Reddy\u2019s Laboratories at 31.16 and Cipla at 33.49, but lower than Divi\u2019s Laboratories at 87.22, Torrent Pharmaceuticals at 86.94, Laurus Labs at 98.88 and Mankind Pharma at 50.06. That places Glenmark in the middle-to-upper range on earnings multiple within this peer set.<\/p>\n<p>On returns, Glenmark\u2019s ROE of 14.10% is below Lupin\u2019s 27.11% and Torrent\u2019s 26.76%, but above Cipla\u2019s 11.83% and Dr. Reddy\u2019s 11.69%. ROCE at 20.35% is stronger than Sun Pharmaceutical Industries at 19.11%, Cipla at 16.00% and Dr. Reddy\u2019s at 13.75%, though slightly below Lupin at 28.86% and Zydus Lifesciences at 21.39%. In market-cap terms, Glenmark at Rs 67,254.14 crore sits below the larger healthcare names in this peer set, while still well above the industry median. That is the core peer context for Glenmark Pharmaceuticals Share Price news and Glenmark Pharmaceuticals stock analysis.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Why_Investors_Are_Watching_Glenmark_Pharmaceuticals\"><\/span><strong>Why Investors Are Watching Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<ul>\n<li>Glenmark Pharmaceuticals Share Price fell 2% today to Rs 2,335.35 from Rs 2,383.<\/li>\n<li>The session range was Rs 2,398.80 to Rs 2,330, with closing price near the day\u2019s low.<\/li>\n<li>Market capitalisation stood at Rs 67,254.14 crore, which places the company in the Large Cap category.<\/li>\n<li>P\/E is 37.41, P\/B is 6.14, ROE is 14.10% and ROCE is 20.35%.<\/li>\n<li>The sector benchmark covers 204 pharmaceuticals and drugs companies, giving a wide comparison base.<\/li>\n<\/ul>\n<h2><span class=\"ez-toc-section\" id=\"About_Glenmark_Pharmaceuticals\"><\/span><strong>About Glenmark Pharmaceuticals<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Glenmark Pharmaceuticals is classified in Healthcare and the Pharmaceuticals &amp; Drugs industry. In this article, Univest is using only the verified company-level and industry-level figures supplied by the workflow. The stock\u2019s market capitalisation is Rs 67,254.14 crore, and the company is part of a broad listed universe where peers range from large healthcare names to mid-sized pharmaceutical companies. For readers following Glenmark Pharmaceuticals Stock News or Glenmark Pharmaceuticals Share News, the current session matters because it combines a same-day price fall with a detailed valuation snapshot. Glenmark Pharmaceuticals Share Price therefore sits in a setting where sector comparison, peer comparison and fundamentals all matter together.<\/p>\n<h2><span class=\"ez-toc-section\" id=\"Track_Glenmark_Pharmaceuticals_Share_Price_on_Univest\"><\/span><strong>Track Glenmark Pharmaceuticals Share Price on Univest<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<p>Use&nbsp;<a href=\"https:\/\/univest.in\/stocks\/glenmark\/glenmark-pharmaceuticals-ltd-share-price-today\">Glenmark Pharmaceuticals (GLENMARK) live share-price page<\/a>,<a href=\"https:\/\/univest.in\/screeners\/top-decliners\">Univest top decliners screener<\/a>,<a href=\"https:\/\/univest.in\/blogs\">Univest market blogs<\/a> to review live stock data, top decliners and related market analysis.<\/p>\n<p>Readers can track Glenmark Pharmaceuticals Share Price on Univest for live price updates, financial ratios, shareholding pattern, 52-week levels and market insights. Univest brings together Glenmark Pharmaceuticals stock news, Glenmark Pharmaceuticals share price update and company analysis in one place, helping users follow the stock with verified data and a clear market context.<\/p>\n<div style=\"background:#CC0000;border-radius:8px;padding:16px 20px;margin:24px 0;\">\n<p style=\"color:#FFFFFF;font-size:13px;line-height:1.7;margin:0;\"><strong style=\"color:#FFFFFF;\">Disclaimer:<\/strong>&nbsp;&nbsp;Data and figures in this article are sourced from publicly available information. These may or may not be accurate. Please verify all data with the official NSE (nseindia.com) and BSE (bseindia.com) websites before making any investment decision. Investments in securities are subject to market risk. This content is for educational purposes only and is not investment advice by Univest (SEBI RA INH000013776).<\/p>\n<\/div>\n<h2><span class=\"ez-toc-section\" id=\"Frequently_Asked_Questions\"><\/span><strong>Frequently Asked Questions<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h2>\n<h3><span class=\"ez-toc-section\" id=\"Why_did_Glenmark_Pharmaceuticals_Share_Price_fall_today\"><\/span><strong>Why did Glenmark Pharmaceuticals Share Price fall today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;The verified data shows Glenmark Pharmaceuticals Share Price fell 2% to Rs 2,335.35. The supplied information confirms the price event, but it does not establish a company-specific catalyst for the decline.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_was_Glenmark_Pharmaceuticals_Share_Price_today\"><\/span><strong>What was Glenmark Pharmaceuticals Share Price today?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals Share Price today closed at Rs 2,335.35 after moving down Rs 47.65 from the previous close of Rs 2,383. The stock opened at Rs 2,398.80 and touched a low of Rs 2,330.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_is_Glenmark_Pharmaceuticals_market_capitalisation\"><\/span><strong>What is Glenmark Pharmaceuticals market capitalisation?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals has a market capitalisation of Rs 67,254.14 crore. That places it in the Large Cap category in the supplied data and well above the industry sample median of Rs 732.57 crore.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"How_does_Glenmark_Pharmaceuticals_compare_with_sector_peers\"><\/span><strong>How does Glenmark Pharmaceuticals compare with sector peers?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals has a P\/E of 37.41, higher than Zydus Lifesciences, Dr. Reddy\u2019s and Cipla, but below Divi\u2019s Laboratories and Torrent Pharmaceuticals. Its ROCE of 20.35% is also above several peers.<\/p>\n<h3><span class=\"ez-toc-section\" id=\"What_do_Glenmark_Pharmaceuticals_fundamentals_show\"><\/span><strong>What do Glenmark Pharmaceuticals fundamentals show?<\/strong><span class=\"ez-toc-section-end\"><\/span><\/h3>\n<p><strong>Ans.<\/strong>&nbsp;&nbsp;Glenmark Pharmaceuticals reports EPS of Rs 63.70, book value of Rs 388.43 and dividend yield of 0.10%. These figures provide context for Glenmark Pharmaceuticals Share Price and help frame the stock\u2019s valuation and earnings profile.<\/p>\n","protected":false},"excerpt":{"rendered":"<p>Glenmark Pharmaceuticals Share Price falls to Rs 2,335.35. marking a 2% fall today. Market cap stands at Rs 67,254.14 crore.<\/p>\n","protected":false},"author":29,"featured_media":273744,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[842],"tags":[],"class_list":["post-273745","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news"],"metadata":{"rank_math_internal_links_processed":["1"],"_thumbnail_id":["273744"],"rank_math_title":["Glenmark Pharmaceuticals Share Price Today After Decline"],"rank_math_description":["Glenmark Pharmaceuticals Share Price fell 2% to Rs 2,335.35. Read the price action, valuation, sector context, and peer comparison."],"rank_math_focus_keyword":["Glenmark Pharmaceuticals Share Price"],"rank_math_robots":["a:2:{i:0;s:7:\"noindex\";i:1;s:8:\"nofollow\";}"]},"jetpack_sharing_enabled":true,"jetpack_featured_media_url":"https:\/\/univest.in\/blogs-2\/wp-content\/uploads\/2026\/09\/glenmark-pharmaceuticals-glenmark-share-price-falls-2-today.webp","_links":{"self":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273745","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/users\/29"}],"replies":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/comments?post=273745"}],"version-history":[{"count":1,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273745\/revisions"}],"predecessor-version":[{"id":273746,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/posts\/273745\/revisions\/273746"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media\/273744"}],"wp:attachment":[{"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/media?parent=273745"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/categories?post=273745"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/univest.in\/blogs-2\/wp-json\/wp\/v2\/tags?post=273745"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}